Your browser doesn't support javascript.
loading
Is the addition of a neurokinin-1 receptor antagonist beneficial in moderately emetogenic chemotherapy?-a systematic review and meta-analysis.
Jordan, Karin; Blättermann, Luisa; Hinke, Axel; Müller-Tidow, Carsten; Jahn, Franziska.
Afiliação
  • Jordan K; Department of Medicine V, Hematology/ Oncology/ Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. karin.jordan@med.uni-heidelberg.de.
  • Blättermann L; Department of Internal Medicine IV, Hematology/Oncology, Martin Luther University Halle-Wittenberg, Ernst-Grube-Strasse 40, 06120, Halle, Germany. karin.jordan@med.uni-heidelberg.de.
  • Hinke A; Department of Internal Medicine IV, Hematology/Oncology, Martin Luther University Halle-Wittenberg, Ernst-Grube-Strasse 40, 06120, Halle, Germany.
  • Müller-Tidow C; WiSP Wissenschaftlicher Service Pharma GmbH, Karl-Benz-Strasse 1, 40764, Langenfeld, Germany.
  • Jahn F; Department of Medicine V, Hematology/ Oncology/ Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Support Care Cancer ; 26(1): 21-32, 2018 01.
Article em En | MEDLINE | ID: mdl-28861627
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vômito / Quimioterapia de Indução / Antagonistas dos Receptores de Neurocinina-1 / Antieméticos / Náusea Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vômito / Quimioterapia de Indução / Antagonistas dos Receptores de Neurocinina-1 / Antieméticos / Náusea Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article